Morocco’s pharmaceutical industry produces a meaningful share of drugs consumed on the domestic market and exports to several African and European countries. It is regulated by the Directorate of Medicines and Pharmacy (DMP) and follows international standards (GMP, ICH, WHO).
Laboratories
- Domestic — Cooper Pharma, Laprophan, Sothema, Pharma 5, Iberma, Synthemedic, Galenica.
- Multinational subsidiaries — Sanofi Morocco, Pfizer Morocco, Novartis, Bayer, GSK, Sandoz, Servier.
- Emerging biotech and CMO players.
Segments
- Pharmaceutical manufacturing (finished drugs, generics, licensed originals);
- Wholesale and distribution (pharmacy groupings, wholesale distributors);
- Community pharmacies;
- Medical devices and in-vitro diagnostics.
Regulation
- DMP — Directorate of Medicines and Pharmacy (Ministry of Health).
- National Council of the Order of Pharmacists.
- GMP inspections domestically; gradual alignment with EMA norms.
Roles
- Pharmacists (technical director, QC head, QA head, pharmacovigilance);
- Production, quality, maintenance and validation engineers;
- Lab technicians and line operators;
- Medical representatives and pharma sales reps;
- Regulatory affairs and market-access specialists.
Training
Faculties of Pharmacy (UM5 Rabat, Casablanca, UM6P, Mohammed VI University of Health Sciences); ISPITS for paramedical staff; engineering schools with a pharmaceutical-processes track.